Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Award of share options/director dealing

16 Apr 2019 07:00

RNS Number : 2619W
LiDCO Group Plc
16 April 2019
 

LiDCO Group Plc

("LiDCO" or the "Company")

 

Award of share options/director dealing

 

LiDCO (AIM: LID), the hemodynamic monitoring company, announces that the Board has yesterday, 15 April 2019, finalised the grant of options ("Options") to Mr Sassone, CEO and Mr Hall, CFO, to subscribe for new ordinary shares of 0.5p.

 

Option type

Number of shares over which options granted

Total number of options held post grant

Percentage of issued share capital under option

Mr Sassone

EMI

Unapproved

-

2,000,000

3,448,262

6,147,342

1.41%

2.52%

Total

2,000,000

9,595,604

3.93%

Mr Hall

EMI

2,000,000

2,000,000

0.82%

 

A proportion of the Options may vest and be exercised at 0.5 pence per Ordinary Share anytime between 9 April 2022 and 9 April 2025 if the average share price in the three months ending 9 April 2022 (the "Average Share Price") equals or exceeds 6.00p. At an Average Share Price of 6.00p, 15% of the Options become exercisable, for all of the Options to vest the Average Share Price must equal or exceed 10.00p, and a straight line sliding scale applies to determine the amount vesting if the Average Share Price is between 6.00p and 10.00p.

 

The Company is currently in the process of finalising share option grants to key employees over a further 1,025,000 Ordinary shares. Following these grants, the total number of shares under option will be 20,478,376 representing 8.4% of the issued share capital.

 

The notifications below are made in accordance with the requirements of the EU Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Matt Sassone

2.

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

LiDCO Group Plc

b)

LEI:

213800PYQTIUV6HIYL36

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of 0.5 pence each

 

GB0030546849

b)

Nature of the transaction:

Grant of Management Share Options

c)

Price(s) and volume(s):

Price(s)

Volume(s)

0.50 pence per share

2,000,000

d)

Aggregated information:

· Aggregated volume:

· Price:

Single transaction as in 4 c) above

Price(s)

Volume(s)

0.50 pence per share

2,000,000

e)

Date of the transaction:

15-04-2019

f)

Place of the transaction:

London Stock Exchange, AIM (XLON)

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Tim Hall

2.

Reason for the notification

a)

Position/status:

Chief Financial Officer

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

LiDCO Group Plc

b)

LEI:

213800PYQTIUV6HIYL36

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of 0.5 pence each

 

GB0030546849

b)

Nature of the transaction:

Grant of Management Share Options

c)

Price(s) and volume(s):

Price(s)

Volume(s)

0.50 pence per share

2,000,000

d)

Aggregated information:

· Aggregated volume:

· Price:

Single transaction as in 4 c) above

Price(s)

Volume(s)

0.50 pence per share

2,000,000

e)

Date of the transaction:

15-04-2019

f)

Place of the transaction:

London Stock Exchange, AIM (XLON)

 

 

For further information, please contact:

LiDCO Group Plc

www.lidco.com

Matt Sassone (CEO)

Tim Hall (CFO)

Tel: +44 (0)20 7749 1500

finnCap

Tel: +44 (0)20 7600 1658

Geoff Nash / Hannah Boros (Corporate Finance)

Andrew Burdis (ECM)

Walbrook PR Ltd

Tel: 020 7933 8780 or lidco@walbrookpr.com

Paul McManus (Media Relations)

Mob: 07876 741 001

Lianne Cawthorne (Media Relations)

Mob: 07584 391 303

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFVRSEIELIA
Date   Source Headline
12th Feb 20207:00 amRNSHolding(s) in Company
6th Feb 20207:00 amRNSGrowth & Innovation Forum 2020
3rd Feb 20207:00 amRNSBlock Listing Review
18th Nov 20199:32 amRNSDirector/PDMR Shareholding
7th Nov 201910:30 amRNSLiDCO to present at Mello London, 2019
5th Nov 20197:00 amRNSLatest monitor launched in China
16th Oct 20197:00 amRNSDirector/PDMR Shareholding
15th Oct 20197:00 amRNSHalf-year Report
12th Sep 20197:00 amRNSCapital Markets Day & technology agreement
20th Aug 20197:00 amRNSCapital Markets Day
20th Aug 20197:00 amRNSTrading update & Notice of results
15th Aug 20197:00 amRNSAppointment of Non-Executive Director
1st Aug 20197:00 amRNSBlock Listing Review
16th Jul 20197:00 amRNSRegulatory approval in China
16th May 201910:30 amRNSResult of AGM
16th May 20197:00 amRNSAGM Statement
23rd Apr 20197:00 amRNSPosting of Annual Report & Accounts &Notice of AGM
17th Apr 20197:00 amRNSRegulatory approval in South Korea
16th Apr 20197:00 amRNSAward of share options/director dealing
2nd Apr 20197:00 amRNSDirector/PDMR Shareholding
1st Apr 20195:48 pmRNSHolding(s) in Company
1st Apr 20197:00 amRNSDirector/PDMR Shareholding
27th Mar 20197:00 amRNSDirector/PDMR Shareholding
26th Mar 20197:00 amRNSFinal Results
12th Mar 20197:00 amRNSMaster distribution agreement for Latin America
8th Mar 20197:00 amRNSHUP progress update
5th Mar 20197:00 amRNSDirectorate Change
20th Feb 20195:00 pmRNSHolding(s) in Company
20th Feb 20197:00 amRNSPre-Close Trading Update and Notice of Results
1st Feb 20197:00 amRNSBlock Listing Review
17th Dec 20187:00 amRNSTrading update and notice of results
12th Oct 201811:20 amRNSHolding(s) in Company
9th Oct 20187:01 amRNSHalf-year Report
9th Oct 20187:00 amRNSUK distribution agreement with Shenzhen Antmed
24th Sep 20187:00 amRNSDirectorate Change
20th Aug 20182:58 pmRNSHolding(s) in Company
20th Aug 20187:00 amRNSTrading update & Notice of results
1st Aug 20188:41 amRNSBlock listing Review
19th Jul 20187:00 amRNSUK distribution agreement with Maicuff Technology
29th Jun 20187:11 amRNSAward of share options/director dealing
17th May 201810:36 amRNSResult of AGM
17th May 20187:00 amRNSAGM Statement
16th May 20187:00 amRNSCapital Markets Day & US progress update
24th Apr 20187:00 amRNSCapital Markets Day
24th Apr 20187:00 amRNSPosting of Annual Report & Accounts& Notice of AGM
10th Apr 20187:00 amRNSFinal Results
20th Mar 20187:00 amRNSEnd of third party UK Distribution agreement
22nd Feb 20187:00 amRNSAppointment of French distributor
15th Feb 20187:01 amRNSTrading update and notice of results
15th Feb 20187:00 amRNSSignificant US & UK HUP wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.